2008
DOI: 10.1159/000129641
|View full text |Cite
|
Sign up to set email alerts
|

Influence of NO Synthase Inhibitor L-NAME on Parasitemia and Survival of <i>Plasmodium berghei</i> Infected Mice

Abstract: Accelerated suicidal death or eryptosis of infected erythrocytes may delay development of parasitemia in malaria. Eryptosis is inhibited by nitric oxide (NO). The present study has been performed to explore, whether inhibition of NO synthase by L-NAME modifies the course of malaria. We show here that L-NAME (>10 µM) increased phosphatidylserine exposure of Plasmodium falciparum infected human erythrocytes, an effect significantly more marked than in noninfected human erythrocytes. We further show that parasite… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
60
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
8

Relationship

5
3

Authors

Journals

citations
Cited by 77 publications
(60 citation statements)
references
References 70 publications
(79 reference statements)
0
60
0
Order By: Relevance
“…A wide variety of clinical disorders is known to stimulate eryptosis, including iron deficiency [36], phosphate depletion [6], hemolytic uremic syndrome [43], sepsis [35], malaria [10,37,38], or Wilson's disease [46]. Some of these diseases may cause eryptosis by stimulating the formation of hemin.…”
Section: Discussionmentioning
confidence: 99%
“…A wide variety of clinical disorders is known to stimulate eryptosis, including iron deficiency [36], phosphate depletion [6], hemolytic uremic syndrome [43], sepsis [35], malaria [10,37,38], or Wilson's disease [46]. Some of these diseases may cause eryptosis by stimulating the formation of hemin.…”
Section: Discussionmentioning
confidence: 99%
“…There is conflicting evidence regarding the role of NO in the process of resistance against malaria parasites. Schizonts treated in vitro with NO donors caused a delayed infection to mice in a dose and time-dependent manner, which, suggest an inhibitory role for NO [58] with influence on parasitemia and survival of Plasmodium berghei in infected mice [59] or P. berghei Anka in rats [60]. Moreover, human severe malaria is associated with decreased NO production [61] and iNOS variants in regions of differing disease manifestation [62].…”
Section: Plasmodium Spmentioning
confidence: 96%
“…The accelerated eryptosis in sickle-cell trait, beta-thalassaemia trait, Hb-C deficiency and G6PD deficiency leads to clearance of infected erythrocytes which counteracts parasitemia and protects against a severe course of malaria [46,[96][97][98]. Parasitemia and clinical course of malaria are further favourably influenced by triggering eryptosis with iron deficiency [99] and treatment with lead [99], chlorpromazine [100] or NO synthase inhibitors [100]. Possibly, the antimalarial effects of nigericin [27] include stimulation of eryptosis of Plasmodium-infected erythrocytes.…”
Section: Discussionmentioning
confidence: 99%